Chemicals & Advanced Materials Global On demand · 24-48h

Global Chelating Agents Market Strategic Research Report

Global Chelating Agents Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Chelating Agents Market
$3.09B2025
3.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Hydroxycarboxylic Acids, Organophosphonates, Aminopolycarboxylates, Others

By Application: Detergent, Water Treatment, Personal Care, Pulp & Paper, Food & Beverage, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BASF, Nouryon, Fuyang Biotech, Dow, Dongxiao Biotech, Kaixiang BioChem, Taihe Chem, PMP, Kemira, Innospec, Jungbunzlauer, AVA Chemicals, Roquette Freres, Langyatai, ADM, Huntsman, Qingshuiyuan, IRO Chelating, Tosoh, Jack Chem

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 133 pages
Market size 2025
$3.09B
Billion USD
Forecast CAGR
3.7%
2025-2032
Forecast 2032
$4B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Chelating Agents market size is predicted to grow from US$ 3,094 million in 2025 to US$ 3,966 million in 2032; it is expected to grow at a CAGR of 3.7% from 2026 to 2032.

Chelating agents are chemical compounds that react with metal ions to form a stable, water-soluble complex. They are also known as chelants, chelators, or sequestering agents.Chelating agents have a ring-like center which forms at least two bonds with the metal ion allowing it to be excreted. Chelating agents are usually organic compounds (a compound that contains carbon).In 2024, global Chelating Agents production reached approximately 1641 K MT, with an average global market price of around US$ 1778 per MT.

The chelating agents market is a sizeable, diversified segment of the specialty chemicals industry, supplying molecules that bind metal ions to improve performance, stability or safety in a wide array of applications. Major end uses include household and industrial detergents (preventing scale and enhancing cleaning), pulp and paper bleaching, water treatment, agriculture (micronutrient delivery), personal care, pharmaceuticals, food and beverage processing, oil and gas, and various industrial processes where metal-catalyzed reactions or deposits must be controlled. The portfolio ranges from traditional aminocarboxylates (like EDTA and NTA) to newer, more biodegradable agents (such as IDS, GLDA, MGDA) and specialized chelates for micronutrient fertilizers and high-purity applications. Global demand grows in the low- to mid–single-digit range, broadly reflecting industrial production, urbanization, and rising living standards, with cleaning, water treatment and agriculture as core engines of consumption and Asia–Pacific holding a growing share of both production and use.

Across the industry chain, the upstream segment is based on petrochemical and inorganic raw materials such as ethylenediamine, formaldehyde, cyanides, caustic soda, ammonia, organic acids, and, in some newer products, bio-based feedstocks and intermediates. Midstream, chelating agents manufacturers synthesize and neutralize these into acid or salt forms through multi-step reactions and purification, then concentrate, standardize and formulate them as liquids, powders or granules, often tailoring pH, stability and metal-binding profiles for specific applications; they also develop high-value metal chelate complexes (e.g., Fe, Zn, Mn, Cu chelates) for agriculture and nutrition. Downstream, formulators of detergents and cleaning products, water-treatment chemicals, agricultural micronutrients, personal care items, pharmaceuticals and food-processing aids integrate chelating agents into finished products to control hardness, prevent scale, improve bleach stability, deliver micronutrients and stabilize formulations. Key demand drivers include the growth of modern cleaning and hygiene, stricter water-quality standards, intensifying agriculture and micronutrient management, and the shift toward more environmentally benign, biodegradable chelants that can replace legacy molecules under regulatory and customer pressure; counterbalancing these are raw-material and energy cost volatility, regulatory scrutiny of certain legacy chemistries, and price competition in commoditized segments. Overall, chelating agents producers typically operate with moderate gross profit margins, most commonly in the range of about 18–30%, with margins toward the higher end for newer biodegradable and specialized metal-chelate products and toward the lower end for high-volume, traditional aminocarboxylate chemistries.

This report presents a comprehensive overview of the global Chelating Agents market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Hydroxycarboxylic Acids
  • Organophosphonates
  • Aminopolycarboxylates
  • Others

Segment by Feature

  • Natural Polymeric Chelating Agents
  • Synthetic Polymeric Chelating Agents

Segment by Channel

  • Direct Selling
  • Distribution

Segment by Application

  • Detergent
  • Water Treatment
  • Personal Care
  • Pulp & Paper
  • Food & Beverage
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Chelating Agents market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Detergent, Water Treatment, Personal Care evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Chelating Agents Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 3.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.09B
2025
Forecast
$4B
2032
CAGR
3.7%
2025–2032
Régions
5
global
Key companies
BASFNouryonFuyang BiotechDowDongxiao BiotechKaixiang BioChemTaihe ChemPMP
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Hydroxycarboxylic AcidsOrganophosphonatesAminopolycarboxylatesOthers
By Application
DetergentWater TreatmentPersonal CarePulp & PaperFood & BeverageOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Hydroxycarboxylic Acids
  • 3.1.3 Organophosphonates
  • 3.1.4 Aminopolycarboxylates
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Detergent
  • 4.1.3 Water Treatment
  • 4.1.4 Personal Care
  • 4.1.5 Pulp & Paper
  • 4.1.6 Food & Beverage
  • 4.1.7 Others
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BASF
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Nouryon
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Fuyang Biotech
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Dow
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Dongxiao Biotech
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Kaixiang BioChem
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Taihe Chem
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 PMP
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Kemira
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Innospec
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Jungbunzlauer
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 AVA Chemicals
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Roquette Freres
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Langyatai
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 ADM
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Huntsman
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Qingshuiyuan
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 IRO Chelating
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Tosoh
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Jack Chem
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Chelating Agents market?
The global Chelating Agents market is estimated at US$ 3.09 billion in 2025 (base year) and is projected to reach US$ 3.97 billion by 2032.
What is the forecast CAGR for the Chelating Agents market?
The market is expected to grow at a CAGR of 3.7% from 2026 to 2032, expanding from US$ 3.09 billion in 2025 to US$ 3.97 billion in 2032, roughly 1.3 times its base-year value.
What is Chelating Agents?
Chelating agents are chemical compounds that react with metal ions to form a stable, water-soluble complex. They are also known as chelants, chelators, or sequestering agents.Chelating agents have a ring-like center which forms at least two bonds with the metal ion allowing it to be excreted. Chelating agents are usually organic compounds (a compound that contains carbon).In 2024, global Chelating Agents production reached approximately 1641 K MT, with an average global market price of around US$ 1778 per MT.
What are the main segments of the Chelating Agents market by type?
By type, the market is segmented into Hydroxycarboxylic Acids, Organophosphonates, Aminopolycarboxylates and Others.
Which applications drive demand in the Chelating Agents market?
Key applications covered include Detergent, Water Treatment, Personal Care, Pulp & Paper, Food & Beverage and Others.
Who are the key players in the Chelating Agents market?
Key players profiled include BASF, Nouryon, Fuyang Biotech, Dow, Dongxiao Biotech, Kaixiang BioChem, Taihe Chem and PMP, among 20 companies covered in total.
Which regions and countries are covered for Chelating Agents?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Chelating Agents market report?
The report is intended for manufacturers and solution providers, distributors and end users in Detergent, Water Treatment and Personal Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Chelating Agents market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.